摘要:
The present invention relates, inter alia, to the use of porous crystalline solids constituted of a metal-organic framework (MOF) for the capture of polar volatile organic compounds (VOCs). In particular, the MOF of interest are material comprising an average pores sizes of 0.4 to 0.6 nm and an hydrophobic core formed by a metal oxide and/or hydroxide network connected by linkers, said linkers being selected from the group comprising (i) C 6 -C 24 aromatic polycarboxylate linkers, such as benzyl or naphtyl di-, tri- or tetracarboxylate, and (ii) C 6 -C 16 polycarboxylate aliphatic linkers; the linkers bearing or not apolar fluorinated groups, e.g. -(CF 2 ) n -CF 3 groups, n being a integer from 0 to 5, preferably 0 ou 3, and/or apolar C 1 -C 20 preferably C 1 -C 4 alkyl groups, e.g. -CH 3 or -CH 2 -CH 3 , grafted directly to the linkers and pointing within the pores of the MOF. The MOF solids used in the present invention can be used for the purification of air, for example for the capture of polar VOCs like acetic acid and aldehydes from indoor air in cars, museums and archives, much more efficiently than common adsorbents, particularly in presence of humidity. They can in particular be used for the preservation of cultural heritage.
摘要:
The present invention relates to an apparatus and a method for separating and analyzing molecules, in particular proteins such as ADCs. To answer ADCs requirements, the apparatus and the method of the present invention are based on the direct connection between non-denaturing chromatography selected from hydrophobic interaction chromatography, size exclusion chromatography and ion exchange chromatography, size exclusion chromatography and non-denaturing mass spectrometry to answer ADCs requirements.
摘要:
The present invention relates to a therapeutic compound comprising: - an agent that inhibits the activity of at least one gene selected from the group consisting of MEOX2, SIX2 and homologues thereof having at least 50% identity with said genes and/or - an agent that enhances the activity of at least one gene selected from the group consisting of CREB5, E2F1, EGR2, HIC1, IRF7, JUN, MYC, SRF, STAT4, TCF4, FOXS1, GLI1, SOX9 and homologues thereof having at least 50% identity with said gene for use in the treatment of wounds, preferably chronic wounds.
摘要:
The invention relates to a method for discriminating cells of a cellular structure, notably of a cellular tissue, comprising the steps consisting in determining (12) a frequency spectrum of the impedance of the cellular structure; defining (22) at least one model of the impedance of the cellular structure including a constant phase element (30); determining (44) the impedance of the constant phase element (30) which optimizes the correlation of each model of the impedance of the cellular structure with the spectrum; and deducing (66), from the impedance of the constant phase element (30) or from the impedances of the constant phase elements (30), an item of information on the cells of the cellular structure. The invention also relates to a system for implementing the method for discriminating cells of a cellular structure.
摘要:
The invention relates to a medical device (12) comprising an electrical measurement circuit (16), in which are connected at least two sensors (22) with variable impedance according to a physical magnitude detected, an electric energy source (18) for powering the electric measurement circuit (16), an antenna (18) for emitting an electromagnetic field in accordance with the impedance of the electrical measurement circuit (16), each of the sensors (22) being associated with a switch (24) so as to short-circuit the sensor (22) in said measurement circuit (16), the medical device (12) also including a system (26) for controlling the switches (24) in order consecutively to control the opening or the closing of the switches (24), according to predetermined configurations. In particular, the medical device (12) can be used on the human body or implanted in the human body.
摘要:
The present invention concerns a method of oxidizing a cycloalkane to form a product mixture containing a corresponding alcohol and ketone, said method comprising contacting a cycloalkane with an oxidant agent in the presence of catalytic effective amount of metal triflates or metal triflimidates catalysts.